There Is No Safe Amount: What Science Now Says About Alcohol and Cancer

For decades, moderate alcohol consumption was associated in observational studies with cardiovascular benefits — giving rise to the idea that a glass of wine with dinner was not merely harmless but possibly protective. That narrative has been substantially revised. The evidence on alcohol and cancer presents a different picture: one with no safe threshold, clear dose-response relationships, and mechanisms that are well-characterised at the molecular level.

How Common Is Alcohol-Attributable Cancer?

The global burden is larger than most people realise. A 2021 population-based study estimated that approximately 741,300 new cancer cases in 2020 — around 4.1% of all cancers diagnosed globally — were attributable to alcohol consumption [1]. The majority of cases occurred in men (77%), and the cancers most commonly attributed to alcohol were oesophageal cancer, liver cancer, and colorectal cancer. Importantly, light and moderate drinkers accounted for a substantial proportion of these cases — not just heavy drinkers.

The Cancer Types Involved

The International Agency for Research on Cancer (IARC) classifies alcohol (ethanol) as a Group 1 carcinogen — the highest certainty classification, shared with tobacco and asbestos. The evidence is sufficient for causality in at least seven cancer types: mouth, pharynx, larynx, oesophagus, liver, colorectum, and female breast. For breast cancer in particular, even low consumption (one drink per day) is associated with a measurable increase in risk.

A 2024 updated review confirmed that the dose-response relationship for alcohol and cancer is broadly linear — meaning risk increases proportionally with consumption, with no evidence of a threshold below which risk is absent [2].

Mechanisms of Carcinogenicity

Alcohol causes cancer through multiple, interacting mechanisms. Ethanol is metabolised to acetaldehyde by alcohol dehydrogenase (ADH) and, to a lesser extent, CYP2E1. Acetaldehyde is a direct-acting mutagen — it forms DNA adducts, impairs the fidelity of DNA replication, and inhibits DNA repair pathways. Acetaldehyde-DNA adducts, particularly N2-ethylidene-dGuo, have been detected in the tissues of alcohol consumers and represent a plausible initiating event in alcohol-attributable cancers.

In the head and neck and oesophagus, alcohol acts as a chemical solvent, increasing mucosal permeability to other carcinogens including tobacco-derived nitrosamines — which explains the supramultiplicative (synergistic) cancer risk in people who both drink and smoke. A 2021 study documented the molecular mechanisms by which alcohol and tobacco co-exposure dramatically accelerates tumour initiation in head and neck squamous cell carcinoma compared to either exposure alone [3].

Additional mechanisms include: generation of reactive oxygen species (ROS) by CYP2E1-mediated alcohol oxidation, causing oxidative DNA damage; folate depletion (alcohol impairs folate absorption and metabolism, compromising methylation-based DNA repair); and oestrogen elevation (alcohol inhibits hepatic oestrogen clearance, increasing breast tissue exposure).

The Cardiovascular Counterargument

The apparent cardioprotective effect of moderate alcohol seen in early observational studies has been substantially undermined by Mendelian randomisation analyses, which use genetic variants in alcohol-metabolising genes as instruments to assess causal effects. These studies are less susceptible to confounding and reverse causation than traditional cohort studies, and they find little or no causal cardioprotective effect while confirming the linear cancer risk relationship [4].

What This Means

The science does not support a safe level of alcohol consumption for cancer prevention. This does not require abstinence as a moral or social directive — it requires informed decision-making. People who choose to drink should be aware that they are accepting a dose-dependent elevation in cancer risk. Reducing consumption, even from moderate to low levels, lowers risk in a proportional and meaningful way.

References

1. Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, Islami F, Lemmens VEPP, Rehm J and Soerjomataram I (2021) Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol 22:1071–1080. doi:10.1016/S1470-2045(21)00279-5.
2. Laskar RS et al. (2024) Alcohol consumption and cancer risk: a dose-response meta-analysis. Ann Oncol 35:250–259. doi:10.1016/j.annonc.2024.02.008.
3. Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, Kalia K and Mandoli A (2021) Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol 121:105451. doi:10.1016/j.oraloncology.2021.105451.
4. Liberale L, Montecucco F, Tardif JC, Libby P and Camici GG (2023) Alcohol and cardiovascular risk: at the crossroad between epidemiology and molecular mechanisms. Int J Mol Sci 24:12913. doi:10.3390/ijms241612913.